PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.05%
Negative revenue growth while 4997.T stands at 186.06%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-14.49%
Negative gross profit growth while 4997.T is at 215.83%. Joel Greenblatt would examine cost competitiveness or demand decline.
-42.44%
Negative EBIT growth while 4997.T is at 4183.45%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-32.96%
Negative operating income growth while 4997.T is at 4183.45%. Joel Greenblatt would press for urgent turnaround measures.
-59.68%
Negative net income growth while 4997.T stands at 38920.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-58.66%
Negative EPS growth while 4997.T is at 38766.67%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-58.66%
Negative diluted EPS growth while 4997.T is at 38766.67%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-90.71%
Negative 10Y revenue/share CAGR while 4997.T stands at 35.97%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-90.71%
Negative 5Y CAGR while 4997.T stands at 35.97%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-15.81%
Negative 3Y CAGR while 4997.T stands at 24.40%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Negative 10Y OCF/share CAGR while 4997.T stands at 100.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Negative 5Y OCF/share CAGR while 4997.T is at 100.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-100.00%
Negative 3Y OCF/share CAGR while 4997.T stands at 100.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
101.62%
Similar net income/share CAGR to 4997.T's 103.83%. Walter Schloss would see parallel tailwinds or expansions for both firms.
101.62%
5Y net income/share CAGR similar to 4997.T's 103.83%. Walter Schloss might see both on parallel mid-term trajectories.
-75.64%
Negative 3Y CAGR while 4997.T is 115.25%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-71.80%
Negative equity/share CAGR over 10 years while 4997.T stands at 26.07%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-71.80%
Negative 5Y equity/share growth while 4997.T is at 26.07%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
120.78%
3Y equity/share CAGR above 1.5x 4997.T's 21.60%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.02%
AR growth is negative/stable vs. 4997.T's 121.27%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-36.90%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-15.23%
Negative asset growth while 4997.T invests at 29.57%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.93%
We have a declining book value while 4997.T shows 12.09%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-44.57%
We’re deleveraging while 4997.T stands at 358.45%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-2.75%
We cut SG&A while 4997.T invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.